SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to…
March 11, 2025 22:20 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…
NEW YORK, March 10, 2025 /PRNewswire/ -- At the inaugural New York Stock Exchange Partnership Day, the NYSE put out…
Stock Buyback Program commencing from today, with broker engaged to execute any open market purchases Stock Buyback Program previously announced…
ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…
![Zelluna ASA [ZLNA]: The first ever cell therapy company to list on the Oslo Stock Exchange following successful completion of the business combination and private placement](https://i1.wp.com/ml-eu.globenewswire.com/media/MjU1NjVjOWEtMTBjOC00MTE0LWI0NTUtYjdlMjkzODM0MzYzLTEyMjA5NDY=/tiny/Zelluna-ASA.png?w=1&resize=1,1&ssl=1)
March 03, 2025 10:46 ET | Source: Zelluna ASA Oslo, Norway, 03 March, 2025 - Zelluna ASA, a company pioneering…
Company Announcement COPENHAGEN, Denmark; February 28, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant…
February 21, 2025 16:05 ET | Source: Intelligent Bio Solutions, Inc. NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent…
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Today, the New York Stock Exchange (NYSE) is hosting its inaugural NYSE Partnership Day,…
WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on…
